2013-01-02 10:15:05 - The US personalized medicine market is projected to grow at a CAGR of 9.5% during 2009-2015, says RNCOS in its research report.
Over the past few years, personalized medicines have emerged as one of the fastest growing sectors in the healthcare industry. Advances in genomics research have paved the way for personalized medicine. The power of the new genomic technologies is that they correlate genetic variation with disease. With the advent of genomic biomarkers, the growth of personalized medicine has been propelled. Moreover, the advancements in proteomics are being used for personalized medicine. Proteomic technologies allow for identification of protein changes caused by the disease process.
According to our report, “Personalized Medicine Market Analysis”, found that many research and development activities are being conducted to introduce personalized medicine for diseases, such as cancer, cardiovascular and neurological disorders. Many people are now offered forms
of personalized cancer treatments, including a targeted treatment, matched with patients on the basis of genetic characteristics. In cardiovascular disease arena, the advances in technologies will continue to move personalized medicine from the stage of research to the clinical setting. Overall, personalized medicines offer huge potential for the treatment of life threatening diseases, and medical communities are recognizing this fact. In future, it is estimated that the market for personalized medicine in the US will grow at a CAGR of 9.5% during 2009-2015.
In addition, the research seeks to present the market’s balanced outlook to clients, giving them an insight into the segment-wise competitive landscape that comprises profiles of pharmaceutical/biotech, diagnostic, IT/informatics, and research tool companies across the globe. Largely, the study aims at depicting the most unbiased picture of the global personalized medicine market to the clients.
Our report, “Personalized Medicine Market Analysis”, provides extensive information and rational analysis of the global personalized medicine market, and thoroughly examines current market trends and industrial developments. Discussing the key market drivers and restraints, the study looks into their impact on the market performance. It also includes a comprehensive overview of the market developments in key countries, including the US, Europe, China, India and Japan.
For FREE SAMPLE of this report visit: www.rncos.com/Report/IM305.htm
Some of our Related Reports are:
- Global Telemedicine Market Analysis ( www.rncos.com/Report/IM331.htm
- Global Regenerative Medicine Market ( www.rncos.com/Report/IM363.htm
- Emerging Pharmaceutical Markets Globally ( www.rncos.com/Report/IM081.htm
- Booming Clinical Trials Market in India ( www.rncos.com/Report/IM564.htm
- Global Obesity Drug Market Analysis ( www.rncos.com/Report/IM335.htm
Check Related REPORTS on: www.rncos.com/Healthcare_Industry.htm
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.